Patent · US Active

Compositions and methods for modulation of LMNA expression

US8258109B2 · kind B2 · utility

25Cited by
7References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 17, 2006
Grant dateSep 4, 2012
Priority date
Expiry dateNov 23, 2026

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/33
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Disclosed herein are compounds, compositions and methods for modulating the expression of LMNA in a cell, tissue or animal. Also provided are methods of target validation. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders. Further provided are methods of identifying cis splicing regulatory elements of a selected mRNA using the disclosed compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.